“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."
The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients. The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here.
Audrey Peart: Dec 20, 2024
December Recap In addition to exhibiting at three trade shows, Pulsara's SVP - Med Ops, Brandon Means, presented the session, 'Emergency Operations...
Kinsie Clarkson: Dec 18, 2024
NORTH POLE, AK — It’s an open secret that there’s a lot of activity going on at the North Pole this time of year. Between checking the list twice,...
Audrey Peart: Nov 27, 2024
NOVEMBER RECAP After a whirlwind November with Team Pulsara exhibiting at eight conferences, our exhibit schedule is slowing down as the year draws...
Brittney Nelson, BSN, RN, SCRN